NervGen Pharma Announces Completion of Dosing of All Subjects in Phase 1 Clinical Trial of Proprietary Drug Candidate NVG-291
Completed NVG-291 dosing of subjects in Phase 1 clinical trial Phase 1b/2a clinical trial of NVG-291 in individuals with spinal cord injury planned to start in Q3 2023 NVG-291 has been demonstrated in preclinical studies to promote repair mechanisms in the nervous system, including axonal regeneration, remyelination and plasticity Vancouver, Canada. February 14, 2023 […]
NervGen Pharma Announces Leadership Transition
Bill Radvak, Co-founder and Executive Chairman of the Board, appointed interim Chief Executive Officer Adam Rogers, member of the Board of Directors, appointed interim President Paul Brennan to step down as President & Chief Executive Officer and member of the Board of Directors; will serve as a strategic advisor for a transition period Vancouver, […]
NervGen Pharma’s NVG-291-R Demonstrates Significant Functional Repair from a Stroke 7 Days After Onset in Landmark Preclinical Study by University of Cincinnati and Case Western Reserve University
The independent peer-reviewed study showed improved memory as well as motor and sensory functions in rodents when treatment with NVG-291-R began 7 days after stroke onset There is currently no FDA-approved drug for the repair of damage from a stroke NVG-291, currently in a Phase 1 clinical trial in healthy human subjects, could provide a […]
NervGen Pharma Grants Stock Options
Vancouver, Canada. July 15, 2022 – NervGen Pharma Corp. (TSX-V: NGEN) (OTCQX: NGENF) (“NervGen” or the “Company”), a clinical stage biotech company dedicated to developing a first-in-class neuroreparative drug to treat nervous system damage, announced that the Company has granted 150,000 incentive stock options to a director exercisable at a price of $1.99 per share […]
NervGen Pharma Closes US$15MM Private Placement and Appoints Dr. Adam Rogers to Board of Directors
Vancouver, Canada. July 14, 2022— NervGen Pharma Corp. (TSX-V: NGEN; OTCQX: NGENF) (“NervGen” the “Company”), a clinical stage biotech company dedicated to developing a first-in-class neuroreparative drug to treat nervous system damage, announced that it has closed its previously announced non-brokered private placement (the “Private Placement”) of 10,150,000 units of the Company at a price of US$1.50 […]
NervGen Pharma Provides Update On Closing Of Private Placement
NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES Vancouver, Canada. July 11, 2022— NervGen Pharma Corp. (TSX-V: NGEN; OTCQX: NGENF) (“NervGen” the “Company”), a clinical stage biotech company dedicated to developing a first-in-class neuroreparative drug to treat nervous system damage, announced that it has received conditional approval from the TSX Venture […]
Disabled and Fit: Talking Adaptive Fitness with Ocean Rehab and Fitness
By Codi Darnell May 31, 2022 Why do we exercise? It’s a question with multiple answers, most of which are rooted in the knowledge that exercise improves health. From blood pressure and bone strength to brain and cardiac health, being physically active is undeniably good for you. But good for you doesn’t mean easy. Both […]
Embracing Your Support System After Brain Injury
By Codi Darnell May 17, 2022 When you experience a brain injury, it can feel as though you’ve been picked up out of your life and deposited onto the sidelines. The life you were living – all your obligations and the daily tasks you completed – still exist, but you’ve been removed from the action. […]
The Outdoor Diaries: Sit-Skiing After Spinal Cord Injury
By Codi Darnell May 3, 2022 Welcome to our blog series: The Outdoor Diaries. This series is about exploring the natural world from the perspective of people with chronic conditions and/or mobility issues. While the benefits of nature are for everybody, access to it isn’t always quite as simple. “Skiing and sunshine, what more do you […]
Emergency Preparedness for People with Disabilities – How I’m Doing It
By Codi Darnell November 30, 2021 When I was a little girl, I feared all natural disasters. From earthquakes and floods to tsunamis and tornadoes, I spent many nights awake in the dark, worrying about it all. And I didn’t discriminate. It didn’t matter that I lived in the pacific northwest and things like hurricanes, […]